Centre Hospitalier Henri Laborit
- Address
- 370 Avenue Jacques Coeur, Cs 10587, 86021 Poitiers, France
Centre Hospitalier Henri Laborit - Psychiatric Research & Addiction Medicine
Centre Hospitalier Henri Laborit is a specialized psychiatric research facility with extensive expertise in mental health disorders and behavioral medicine. The center demonstrates particular strength in investigating novel therapeutic approaches for major depressive disorder (MDD) and early psychosis, conducting multiple phase 3 clinical trials evaluating innovative pharmacological interventions and personalized care strategies.
- Major Depressive Disorder treatment, including studies of kappa opioid receptor antagonists and adjunctive therapies for treatment-resistant depression and anhedonia
- Early psychosis intervention, focusing on ultra-high risk populations and first episode psychosis with composite personalized care approaches
- Smoking cessation research utilizing electronic cigarettes and licensed cessation medications
The center's research portfolio emphasizes personalized medicine approaches integrating biological testing, digital cognitive reinforcement tools, and comprehensive clinical profiling. Their work on relapse prevention and long-term safety evaluation of emerging psychiatric medications positions them at the forefront of psychiatric care innovation, with particular attention to functional outcomes and quality of life improvements for patients with severe mental health conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Neumora Therapeutics Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Henri Laborit
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Trial Comparing Nicotine-Containing Electronic Cigarettes, Varenicline, and Nicotine-Free Electronic Cigarettes in Smokers | Assistance Publique Hopitaux De Paris | Phase III | Not Yet Recruiting | Oct 2024 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 1-[6-Ethyl-8-Fluoro-4-Methyl-3-(3-Methyl-1,2,4-Oxadiazol-5-Yl)Quinolin-2-Yl]-N-(Oxan-4-Yl)Piperidin-4-Amine | 2 | Unknown | 2024-07-18 | 2024-09-30 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.